|
|
Discussion on the co-construction mode of traditional Chinese medicine discipline under the construction of medical consortium |
ZHENG Yang1 LI Zhe1 FAN Jie1 LIU Baoli1 QIU Xinping2 LIU Qingquan1 |
1.Office of Academic Research, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China;
2.Office of Academic Research, Beijing Hospital of Traditional Chinese Medicine Shunyi Hospital, Beijing 101300, China |
|
|
Abstract The construction of medical consortium (hereinafter referred to as “medical consortium”) is an important step and institutional innovation to deepen medical reform. In 2013, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University took charge of Beijing Shunyi District Hospital of Traditional Chinese Medicine, and medical consortium internal traditional Chinese medicine discipline co-construction was carried out between the two hospitals. Beijing Shunyi District Hospital of Traditional Chinese Medicine has achieved rapid development in medical services, scientific research capabilities, talent training and other aspects through exploration and practice of clear responsibility and right, system construction, discipline homogenization construction, needle and drug combination construction, and experimental platform construction. medical consortium internal traditional Chinese medicine discipline co-construction promotes the integration of the two hospitals, realizes the improvement of the management model of medical consortium through the joint construction of disciplines, and promotes the smooth progress of hierarchical medical treatment and medical reform.
|
|
|
|
|
[1] 国务院办公厅.国务院办公厅关于推进医疗联合体建设和发展的指导意见[J].国务院公报,2017,13:14-18.
[2] 黄亦恬,陶红兵,江恬雨,等.医疗联合体实现条件与关键问题探讨[J].中国医院管理,2018,38(9):4-7.
[3] 孙新颜.医联体上下贯通学科建设是纽带[N].健康报,2017-04-17(005).
[4] 徐建德.医联体的模式及未来发展趋向研究[J].中国卫生标准管理,2019,10(2):29-32.
[5] 王洪,刘清泉,孙颂歌.市、区、镇一体化区域中医医联体的建设与初步成效[J].中医药管理杂志,2016,24(15):166-168.
[6] 金建军,杨鲲,陈颖淑,等.“华山医院—静安”医联体分级转诊工作的做法与思考[J].中国医院管理,2019,39(1):78-80.
[7] 国务院办公厅.国务院办公厅印发《深化医药卫生体制改革2017年重点工作任务》[N].人民日报,2017-05-06(004).
[8] 金春林,李芬.分级诊疗制度建设的要素及抓手[J].卫生经济研究,2017,11:3-4.
[9] 黄佳文,雷海潮.北京市医疗联合体现状与思考:基于深度访谈法[J].中国医院,2019,23(5):46-49.
[10] 时硕,白婧.北京市区域医疗联合体系建设问题探究[J].中国医院管理,2015,10(35):8-10.
[11] 焦翔,陈国强,程纯,等.基于医联体平台的上海市不同等级医院协作机制研究[J].中国医院管理,2019,39(4):23-25.
[12] 国务院办公厅.国务院办公厅关于建立现代医院管理制度的指导意见[J].国务院公报,2017,23:17-21.
[13] 董四平,郭淑岩,何柳,等.中国医院排行榜现状分析与对策探讨[J].中国医院管理,2015,35(3):38-40.
[14] 潘利民,滕金亮,王宽垒,等.加强人才培养工作对我院重点学科建设的影响及成效[J].中国医药导报,2015, 12(27):147-152.
[15] 李永昌,方钱,刘鹏,等.医院优势学科的培育路径与实现之策[J].医学研究生学报,2018,31(8):848-852.
[16] 国卫科教发〔2016〕51号.关于加强卫生与健康科技成果转移转化工作的指导意见[J].国家卫生计生委公报,2016(10):16-21.
[17] 谭忠婕,秦彦文.医学科研院所科技成果转化的问题及对策[J].北京生物医学工程,2018,37(4):410-412,438.
[18] 廖华君,钟玉梅,许帅,等.《伤寒论》针药结合溯源[J].时珍国医国药,2019,30(1):157-159.
[19] 梁浩,于莹,周忠光,等.针药联合治疗高血压合并动脉粥样硬化的临床观察[J].中国医药导报,2019,16(30):147-150,167.
[20] 盖晓丽,王德强.针药并用的临床体会[J].中医外治杂志,2019,28(4):67-69.
[21] 戴春晓,洪媚,谢健,等.针药治疗抑郁症残留疼痛症状的疗效对照研究[J].中国现代医生,2018,56(33):19-22,26.
[22] 宋凯,王亚军,宋亚文,等.针药结合模式浅析[J].中医药临床杂志,2016,28(12):1660-1662.
[23] 迟文成,王彬彬,杨帆,等.针药联合治疗非小细胞肺癌患者化疗后癌因性失眠的临床效果[J].中国医药导报,2019,16(23):114-117. |
|
|
|